









Markets
/
Stocks
/
nasdaq-ppcb
/

Propanc Biopharma Ord Shs

PPCB

0.711USD

-0.009-1.25%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

9.47MMarket Cap

0.03P/E TTM



Propanc Biopharma Ord Shs

0.711

-0.009-1.25%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Propanc Biopharma Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

Total equity

Cash, cash equivalents and short-term investments

--602.74K

- Cash and cash equivalents

--602.74K

Receivables

--8.38K

Prepaid expenses

--8.14M

Other current assets

--8.83K

Total current assets

--8.76M

Non-current assets

Net Fixed Assets

--58.64K

-Fixed Assets

--156.08K

-Accumulated depreciation

--97.44K

Long-term prepaid expenses

--9.14M

Other non-current assets

--9.15M

Total non-current assets

--9.21M

Total assets

--17.98M

Liabilities

Current liabilities

Accrued expenses

--1.53M

Short-term debt and lease liabilities

--632.49K

-Short-term debt

--632.49K

Total current liabilities

--3.57M

Non-current liabilities

Long-term debt and lease liabilities

--42.08K

-Long-term debt

--0.00

-Long-term lease liabilities

--42.08K

Total non-current liabilities

--42.08K

Total liabilities

--3.61M

Shareholders' equity

Common equity

--143.53M

Retained earnings

---130.46M

Capital reserves

--143.52M

Less: Treasury stock

--46.48K

Gains losses not affecting retained earnings

--1.34M

Total equity

--14.36M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

